Imperative Care announced that it launched the Ikon 24 Pro guidewire, a next-generation neurovascular device for treating stroke. Campbell, California-based Imperative Care purpose-built the guidewire to improve vascular access during stroke procedures. It says it engineered the Ikon 24 Pro to incorporate three core capabilities. First, the … [Read more...] about Imperative Care launches new guidewire purpose-built for stroke
Imperative Care
Imperative Care launches study of thrombectomy systems for vascular disease
Imperative Care announced today that it enrolled the first patient in the CLEAR-IT study evaluating its Symphony and Prodigy systems. Symphony, a large-bore aspiration catheter system, aims to deliver more efficient and effective clot removal. It combines large-bore power with deep vacuum control to help remove more clot in less time. Prodigy … [Read more...] about Imperative Care launches study of thrombectomy systems for vascular disease
Imperative Care launches new Zoom 4S catheter
Imperative Care announced the launch of the new Zoom 4S thrombectomy catheter and reported the first patient cases with the device. The Campbell, California–based company said in a news release that Zoom 4S represents its latest innovation in ischemic stroke treatment. It built Zoom 4S for ease of use and to empower physicians with a device … [Read more...] about Imperative Care launches new Zoom 4S catheter
Imperative Care reports positive results for next-gen stroke aspiration approach
Imperative Care announced new real-world data evaluating ADAPT 2.0, a next-generation approach to stroke treatment. ADAPT (A Direct Aspiration First Pass Technique) 2.0 combines 0.088” intracranial access, asymmetric aspiration, and the continuous dual aspiration technique (CDAT) to provide fast and effective clot removal. Campbell, … [Read more...] about Imperative Care reports positive results for next-gen stroke aspiration approach
Imperative Care reports positive outcomes with Symphony thrombectomy system in acute PE
Imperative Care today announced positive efficacy and safety results from its pivotal SYMPHONY-PE study. SYMPHONY-PE evaluates the company’s Symphony thrombectomy system in the treatment of acute pulmonary embolism (PE). Campbell, California-based Imperative Care designed Symphony, a large-bore aspiration catheter system, to deliver more … [Read more...] about Imperative Care reports positive outcomes with Symphony thrombectomy system in acute PE
FDA clears Imperative Care Symphony thrombectomy system for pulmonary embolism
Imperative Care announced today that the FDA granted 510(k) clearance for its Symphony thrombectomy system to treat pulmonary embolism (PE). The clearance expands the use of Symphony, which previously served as a treatment for venous thrombosis, to PE. It delivers a comprehensive solution for treating the full spectrum of venous thromboembolism … [Read more...] about FDA clears Imperative Care Symphony thrombectomy system for pulmonary embolism
Imperative Care wins FDA nod for new Zoom 7X catheter
Imperative Care announced today that it received FDA 510(k) clearance for its novel Zoom 7X catheter for aspiration thrombectomy procedures. The company also reported the first patient cases with its latest advancement for ischemic stroke treatment. Campbell, California-based Imperative Care said it marks the first catheter to incorporate its … [Read more...] about Imperative Care wins FDA nod for new Zoom 7X catheter
Imperative Care has positive stroke treatment study results
Imperative Care today announced study data evaluating aspiration with its Zoom system in stroke patients with M2 occlusions. Campbell, California–based Imperative Care designed Zoom for fast and effective clot removal from access through reperfusion. It treats patients with acute ischemic stroke, enabling smooth tracking through challenging … [Read more...] about Imperative Care has positive stroke treatment study results
Imperative Care completes enrollment in pulmonary embolism study
Imperative Care announced today that it completed enrollment in the SYMPHONY-PE pivotal investigational device exemption (IDE) study. The FDA IDE study evaluates the company's Symphony Thrombectomy System for treating acute pulmonary embolism (PE). Designed to expand Symphony's current indication for use to include PE, investigators conducted … [Read more...] about Imperative Care completes enrollment in pulmonary embolism study
Imperative Care expands Zoom Stroke System with new dual-catheter launch
Imperative Care announced today that it expanded its Zoom Stroke System with the launch of its Zoom DuoPort technology. Zoom DuoPort allows physicians to continue using the novel continuous dual-aspiration technique (CDAT) on two Zoom aspiration catheters simultaneously from a single vacuum source. CDAT enables enhanced aspiration control and … [Read more...] about Imperative Care expands Zoom Stroke System with new dual-catheter launch







